Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

New Research Uncovers How Life-Threatening Fungal Diseases Adapt to Survive in Humans

By Westmead Institute for Medical Research | May 6, 2019

Researchers Associate Professor Julie Djordjevic and Dr Sophie Lev. Credit: The Westmead Institute for Medical Research

A new study from The Westmead Institute for Medical Research has uncovered how serious fungal infections grow in humans by conserving phosphate, highlighting a possible target for treatment.

Cryptococcus neoformans is a potentially life-threatening invasive fungal disease that infects people with weakened immune systems, such as cancer patients and organ transplant recipients. The fungus needs phosphate to grow and sustain an infection in its host, as phosphate is essential for functions such as cell division.

Researchers found that, in environments with limited phosphate, Cryptococcus neoformans remodels lipids – fatty acids in the cell membrane – to release phosphate.

Lead researcher, Associate Professor Julie Djordjevic, said, “This is the first time that this strategy of conserving phosphate has been described in a human fungal pathogen.

“Fungi encounter phosphate starvation when they infect humans. However, fungal infections are quite clever, and have unique strategies to conserve phosphate when it becomes scarce.

“We found Cryptococcus neoformans conserves phosphate by activating a gene, BTA1, which encodes an enzyme that produces betaine lipids. Production of these betaine lipids allows the fungal pathogen to recycle phosphate from the lipids it normally produces, helping it to survive and spread.

“Fungi that were missing the BTA1 gene grew more slowly than cells with the gene and were less able to cause disease in animal infection models, indicating the essential role of phosphate conservation in the development of Cryptococcus neoformans infections.”

Cryptococcus neoformans initially infects the lungs, where it can spread to the brain, causing the life-threatening condition, Cryptococcal meningitis. Invasive fungal diseases including those caused by Cryptococcus neoformans cause 1.6 million deaths worldwide each year.

Associate Professor Julie Djordjevic said the high rates of mortality are, partly, due to a lack of new treatments.

“The growing emergence of drug resistant strains of fungi, as well as a lack of effective existing treatments, means we need new therapies to combat invasive fungal diseases.

“Now that we understand how Cryptococcus neoformans conserves phosphate, we can investigate how we can prevent this process from occurring to stop the growth and spread of infection.”


Filed Under: Infectious Disease

 

Related Articles Read More >

Vaccines, autism and America: A stress test for public health standards
RSV at IDWeek 2025: Competitive expansion of preventive and therapeutic modalities
Top 25 drugs by sales: 2025 H1
Bipartisan support for vaccines could be a balm for beleaguered vaccine companies
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE